About Contact Us Careers
Sign In

VEGF Inhibitor Drugs Market - Top Companies and Manufacturers

  • Report ID: 2479
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Companies Dominating the Vascular Endothelial Growth Factor (VEGF) Inhibitors Landscape

    • Pfizer, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Novartis AG
    • GlaxoSmithKline plc
    • Sanofi
    • AstraZeneca plc
    • Bristol-Myers-Squibb Company
    • Genentech, Inc. (Roche)
    • Merck & Co., Inc.
    • Bayer AG
    • Eli Lilly & Company

     

Browse Key Market Insights with Data Illustration:

In the News


Author Credits:  Radhika Pawar


  • Report ID: 2479
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing cases of cancer coupled with the rising demand for combination therapies are some of the major factors responsible for market growth.

The market is anticipated to attain a CAGR of 9% over the forecast period, i.e. 2020-2028.

Rising investments in research and development of VEGF inhibitor drugs and effective cancer therapies in North America will provide more business opportunities for market growth.

The major players in the global market are Pfizer, Inc., Novartis AG, GlaxoSmithKline plc, Sanofi, AstraZeneca plc, Bristol-Myers-Squibb Company, Genentech, Inc. (Roche), Merck & Co., Inc., Bayer AG and Eli Lilly & Company.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample